← Open Payments lookup

OSHANI PIERIS-STEELMAN: Open Payments

NPI 1841711488 · EDMOND, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,096 in 122 payments from 14 companies in 2025. Trend: 2023 $19 · 2024 $1,136 · 2025 $2,096

Food & beverage: $2,096
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)27$445
ABBVIE INC.30$332
Alkermes, Inc.12$233
Janssen Pharmaceuticals, Inc12$205
Otsuka America Pharmaceutical, Inc.10$204
Teva Pharmaceuticals USA, Inc.8$181
E.R. Squibb & Sons, L.L.C.8$153
Takeda Pharmaceuticals U.S.A., Inc.5$103
Vanda Pharmaceuticals Inc.2$58
IDORSIA PHARMACEUTICALS US INC2$47

Products named: CAPLYTA, VRAYLAR, COBENFY, REXULTI, SPRAVATO, ARISTADA, AUSTEDO XR, LYBALVI.

Industry payments across OK — which companies pay providers there.